20-HETE Ethanolamide – 25 µg

Brand:
Cayman
CAS:
942069-11-6
Storage:
-20
UN-No:
De Minimis - 1170 / 3

Arachidonoyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.{2713,14062} Fatty acid amide hydrolase (FAAH) is the enzyme responsible for the hydrolysis and inactivation of AEA.{13132} Metabolism of AEA by cyclooxygenase-2, leading to formation of prostaglandin ethanolamides, and by lipoxygenases has also been documented.{12168} 20-HETE ethanolamide is a potential cytochrome P450 metabolite of arachidonoyl ethanolamide, which may be particularly relevant under conditions of fatty acid amide hydrolase inhibition. Evidence for the formation of 20-HETE ethanolamide in vivo has not been documented.  

 

Available on backorder

SKU: 10008602 - 25 µg Category:

Description

20-HETE ethanolamide is a potential CYP450 metabolite of AEA, which may be particularly relevant under conditions of FAAH inhibition. Evidence for the formation of 20-HETE ethanolamide in vivo has not been documented.


Formal name: 20-hydroxy-N-(2-hydroxyethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide

Synonyms:  20-hydroxy AEA|20-hydroxy Arachidonoyl Ethanolamide

Molecular weight: 363.5

CAS: 942069-11-6

Purity: ≥98%

Formulation: A solution in ethanol


Product Type|Biochemicals|Lipids|Fatty Amides||Product Type|Biochemicals|Lipids|Hydroxy/Hydroperoxy/ Epoxy/Oxo Eicosanoids||Research Area|Lipid Biochemistry|Cytochrome P450 Pathways||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids